Oncology Institute
(NASDAQ) TOI
Oncology Institute Financials at a Glance
Market Cap
$306.40M
Revenue (TTM)
$502.73M
Net Income (TTM)
$60.61M
EPS (TTM)
$-0.56
P/E Ratio
-5.50
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$2.95
Volume
53,363
Open
$3.10
Price
$2.95
Volume
53,363
Open
$3.10
Previous Close
$2.95
Daily Range
$2.94 - $3.16
52-Week Range
$0.97 - $4.88
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$2.95
Volume
53,363
Open
$3.10
Previous Close
$2.95
Daily Range
$2.94 - $3.16
52-Week Range
$0.97 - $4.88
TOI News
TOI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Oncology Institute
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
641
CEO
Daniel Virnich, MD, MBA
Website
www.theoncologyinstitute.comHeadquarters
Cerritos, CA 90703, US
TOI Financials
Key Financial Metrics (TTM)
Gross Margin
14%
Operating Margin
-7%
Net Income Margin
-12%
Return on Equity
-3408%
Return on Capital
-39%
Return on Assets
-37%
Earnings Yield
-18.18%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$306.40M
Shares Outstanding
98.84M
Volume
53.36K
Short Interest
0.00%
Avg. Volume
2.07M
Financials (TTM)
Gross Profit
$69.49M
Operating Income
$36.08M
EBITDA
$29.14M
Operating Cash Flow
$24.59M
Capital Expenditure
$3.20M
Free Cash Flow
$27.79M
Cash & ST Invst.
$33.56M
Total Debt
$103.69M
Oncology Institute Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$141.96M
+41.6%
Gross Profit
$15.82M
+8.1%
Gross Margin
11.14%
N/A
Market Cap
$306.40M
N/A
Market Cap/Employee
$371.40K
N/A
Employees
825
N/A
Net Income
$7.51M
+43.0%
EBITDA
$5.36M
+152.0%
Quarterly Fundamentals
Net Cash
$7.28M
+109.9%
Accounts Receivable
$59.32M
+21.9%
Inventory
$16.88M
+68.1%
Long Term Debt
$19.13M
-83.6%
Short Term Debt
$7.16M
+5.3%
Return on Assets
-36.81%
N/A
Return on Invested Capital
-38.51%
N/A
Free Cash Flow
$2.17M
-10.6%
Operating Cash Flow
$3.23M
-22.8%